Follow
Daniel Schuette
Daniel Schuette
University Hospital Cologne
Verified email at uk-koeln.de - Homepage
Title
Cited by
Cited by
Year
Drugging the catalytically inactive state of RET kinase in RET-rearranged tumors
D Plenker, M Riedel, J Brägelmann, MA Dammert, R Chauhan, ...
Science translational medicine 9 (394), eaah6144, 2017
632017
Mechanisms of Primary Drug Resistance in FGFR1-Amplified Lung Cancer
F Malchers, M Ercanoglu, D Schütte, R Castiglione, V Tischler, S Michels, ...
Clinical Cancer Research 23 (18), 5527-5536, 2017
562017
Neuronal calcium sensor 1 (NCS1) promotes motility and metastatic spread of breast cancer cells in vitro and in vivo.
JE Apasu, D Schuette, R LaRanger, JA Steinle, LD Nguyen, ...
FASEB Journal, 2018
172018
Hepatocellular carcinoma outcome is predicted by expression of neuronal calcium sensor 1
D Schuette, LM Moore, ME Robert, TH Taddei, BE Ehrlich
Cancer Epidemiology, Biomarkers & Prevention 27 (9), 1091-1100, 2018
132018
Mechanistic insight into RET kinase inhibitors targeting the DFG-out conformation in RET-rearranged cancer
D Plenker, M Riedel, J Brägelmann, MA Dammert, R Chauhan, ...
Science Translational Medicine 9 (394), 2017
22017
Smoking-associated gene expression alterations in nasal epithelium reveal immune impairment linked to lung cancer risk
MS de Biase, F Massip, TT Wei, FM Giorgi, R Stark, A Stone, A Gladwell, ...
Genome Medicine 16 (1), 54, 2024
2024
High Expression of Neuronal Calcium Sensor 1 Induces an Invasive Cellular Phenotype and Predicts Poor Disease Outcome in a Subset of Cancer Patients
D Schütte
Universität zu Köln, 2023
2023
Neuronal Calcium Sensor 1 (NCS1) Expression Levels Predict Survival in a Cohort of Asian Hepatocellular Carcinoma (HCC) Patients
D Schuette, TH Taddei, ME Robert, BE Ehrlich
American College of Physicians, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–8